Dr. Fleshner's clinical practice is in urologic oncology with research interests in prostate and bladder cancer.
Expression of Small Non-coding RNAs in Urinary Exosomes Classifies Prostate Cancer into Indolent and Aggressive Disease.
J Urol. 2020 Mar 19;:101097JU0000000000001020
J Urol. 2020 Mar 16;:101097JU000000000000059502
Clinical-genomic Characterization Unveils More Aggressive Disease Features in Elderly Prostate Cancer Patients with Low-grade Disease.
Eur Urol Focus. 2020 Mar 07;:
Long-term use of 5-alpha-reductase inhibitors is safe and effective in men on active surveillance for prostate cancer.
Prostate Cancer Prostatic Dis. 2020 Mar 09;:
Testosterone Breakthrough Rates during Androgen Deprivation Therapy for Castration Sensitive Prostate Cancer.
J Urol. 2020 Feb 25;:101097JU0000000000000809
A noninvasive urine-based methylation biomarker panel to detect bladder cancer and discriminate cancer grade.
Urol Oncol. 2020 Feb 18;:
A High Percent-Free PSA in the Setting of Biochemical Recurrence after Radical Prostatectomy is Associated With Poorer Outcomes: A Validation Study Using Prospectively Collected Biobank Specimens.
J Urol. 2020 Feb 18;:101097JU0000000000000808
Canadian Urological Association-Canadian Urologic Oncology Group guideline on metastatic castration-naive and castration-sensitive prostate cancer.
Can Urol Assoc J. 2020 Feb;14(2):17-23
Gender-based psychological and physical distress differences in patients diagnosed with non-metastatic renal cell carcinoma.
World J Urol. 2020 Jan 01;:
BJU Int. 2019 Dec 21;:
Martin Barkin Chair, Division of Urology, Department of Surgery, University of Toronto
Professor, Department of Surgery, University of Toronto